# The Effect of Salmeterol on Eosinophil (EOS) Function

> **NCT00214019** · NA · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 36 (actual)

## Conditions studied

- Allergic Asthma

## Interventions

- **DRUG:** salmeterol
- **DRUG:** Fluticasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00214019
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214019, "The Effect of Salmeterol on Eosinophil (EOS) Function". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00214019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*